Single Page FAQ-Style Patient Website for Farydak May 3, 2018May 1, 2018 Brand: Farydak (panobinostat), Capsules Parent Company: Novartis Drug Type: Boxed Warning Drug Category: Oncology Campaign: Launch, Post-Launch Targeting: Patients Patient Website: https://www.us.farydak.com/ HCP Website: https://www.hcp.novartis.com/products/farydak/multiple-myeloma/ Single-page site Farydak May Help How To Take Support